802 articles
Major fitness chain deploys cordless metabolic testing masks across all locations, offering lab-grade VO2 max assessments during workouts.
Chinese biotech begins multicenter trial of stem cell therapy showing promising early results for Parkinson's motor symptoms and quality of life.
Mountain View biotech's RLS-1496 becomes first GPX4-targeting senolytic to enter human trials, using AI platform to eliminate aging cells.
The FDA will convene advisory panels in July 2025 to reconsider whether compounding pharmacies can legally produce certain popular peptides removed from approved lists in 2023.
FDA will reconsider allowing compounding pharmacies to produce 12 peptides removed in 2023, following advocacy from health officials.
Biotech company secures massive funding following breakthrough trial results showing experimental drug doubled survival in advanced pancreatic cancer.
Decade-long analysis finds negligible clinical benefits from new Alzheimer's drugs, sparking debate among experts about treatment effectiveness.
Major review sparks fresh controversy over effectiveness of amyloid-targeting Alzheimer's treatments currently approved by FDA.
Researchers who developed Zepbound are testing a new obesity drug that targets different hormones and may cause less nausea than current treatments.
Breakthrough CAR-T treatments offer new hope for previously hard-to-treat cancers including pancreatic cancer and B-cell lymphoma.
Breakthrough antibodies completely prevent EBV infection in lab models, offering hope against virus linked to cancer and chronic disease.
China-based Immorna and another startup enter clinical trials testing RNA-based CAR-T treatments for autoimmune conditions.
